0 التعليقات
0 المشاركات
1527 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
- الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
- A New Hope for DMD: Sarepta’s ELEVIDYS Gene TherapySarepta’s ELEVIDYS: First Gene Therapy for Duchenne Muscular Dystrophy (DMD) Treatment Duchenne muscular dystrophy (DMD) is a devastating genetic disorder that primarily affects boys, leading to progressive muscle degeneration and weakness. Historically, DMD has been managed through supportive care, steroids, and emerging pharmaceutical therapies, but there has been no cure. The...0 التعليقات 0 المشاركات 252 مشاهدة 0 معاينة
- Duchenne Muscular Dystrophy (DMD) Treatment Market Trends and Segments Forecast To 2029The global duchenne muscular dystrophy (dmd) treatment market size was valued at USD 3.8 billion in 2022 and is poised to grow at a significant CAGR of 38.2% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth...0 التعليقات 0 المشاركات 1151 مشاهدة 0 معاينة
- Understanding Corticosteroid Therapy in Duchenne Muscular Dystrophy (DMD) TreatmentCorticosteroid therapy is a cornerstone of Duchenne Muscular Dystrophy (DMD) treatment. These medications, such as prednisone and deflazacort, have shown significant benefits in slowing disease progression and prolonging ambulation in individuals with DMD. Corticosteroids work by reducing inflammation and suppressing muscle fiber damage, thus preserving muscle strength and function. However,...0 التعليقات 0 المشاركات 1556 مشاهدة 0 معاينة
- Advances in Duchenne Muscular Dystrophy TreatmentCauses and Mechanism of Duchenne Muscular Dystrophy Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It is caused by the absence of dystrophin, a protein that helps keep muscle cells intact. The defective gene that causes DMD is located on the X chromosome, so it primarily affects boys. Girls can be carriers of the defective...0 التعليقات 0 المشاركات 612 مشاهدة 0 معاينة
- Breakthroughs in Alzheimer’s Disease Research: What’s on the Horizon?What Does the Future Hold For Gene Therapy in the Duchenne Muscular Dystrophy (DMD) Treatment Market? Duchenne muscular dystrophy (DMD) is a severe, X-linked genetic disorder characterized by progressive muscle degeneration and weakness. Affecting approximately 1 in 3,500 to 5,000 males globally, DMD is caused by mutations in the dystrophin gene, leading to the absence of dystrophin...0 التعليقات 0 المشاركات 260 مشاهدة 0 معاينة
- NASH: Meeting the Unmet Challenges in Liver HealthNASH: Meeting the Unmet Challenges in Liver Health Meeting the Unmet: Nonalcoholic Steatohepatitis (NASH) Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease that represents a significant unmet medical need. Characterized by inflammation and damage in the liver, NASH is a severe form of nonalcoholic fatty liver disease (NAFLD), and its prevalence has been steadily increasing...0 التعليقات 0 المشاركات 239 مشاهدة 0 معاينة
- Next-Gen Therapeutic Strategies: Nucleic Acids and Gene Therapies for Neuromuscular DisordersNucleic Acids and Gene Therapies in Neuromuscular Disorders: Next-Generation Therapeutic Strategies Neuromuscular disorders (NMDs) are a diverse group of conditions characterized by the progressive degeneration of muscle and nerve function. Among these, Duchenne muscular dystrophy (DMD) stands out as a devastating condition with no cure, resulting from mutations in the dystrophin gene....0 التعليقات 0 المشاركات 217 مشاهدة 0 معاينة